Evidence map›Paper›PMID 42482591›Full record

ArticleZoonoses and public health2026

Canine Leishmaniosis in Italy: Geospatial Trends and Incidence, a Shift in Epidemiological Approach.

Federica Bruno, Germano Castelli, Eugenia Oliveri, Gaetano Oliva, Mariele De Santi, Claudia La Rocca, Ornella Melideo, Marco Ripamonti, Francesco La Russa, Maria Liliana Di Pasquale and 7 more

Abstract read
In one paragraph

Article in Zoonoses and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Federica BrunoWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.
Germano CastelliWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.ORCID https://orcid.org/0000-0002-0464-4474
Eugenia OliveriWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.ORCID https://orcid.org/0000-0002-1045-3359
Gaetano OlivaDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.
Mariele De SantiDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.ORCID https://orcid.org/0000-0003-0466-5563
Claudia La RoccaDepartment of Veterinary Medicine and Animal Production, University of Naples "Federico II", Naples, Italy.
Ornella MelideoElanco Italia S.P.A., Sesto Fiorentino, Italy.
Marco RipamontiElanco Italia S.P.A., Sesto Fiorentino, Italy.
Francesco La RussaWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.ORCID https://orcid.org/0000-0003-0947-853X
Maria Liliana Di PasqualeWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.ORCID https://orcid.org/0000-0001-7777-1469
Antonella GalanteWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.
Roberto HamelWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.ORCID https://orcid.org/0009-0007-5268-3551
Giorgio SchieraWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.ORCID https://orcid.org/0009-0004-2325-3008
Marzio CometaWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.
Silvia ScibettaWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.ORCID https://orcid.org/0000-0002-8239-1679
Stefano RealeWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.
Fabrizio VitaleWOAH Leishmania Reference Laboratory, Istituto Zooprofilattico Sperimentale Della Sicilia, Palermo, Italy.

Funding

Ministero della Salute GR-2019-12369134Ministero della Salute IZS SI RC 06/23
6 · The paper itself

Abstract

introductionCanine leishmaniosis (CanL) has shown a marked geographic expansion in Italy, progressively affecting central and northern regions previously considered non-endemic. Laboratory-based prevalence estimates remain informative in well-designed surveys; however, prevalence derived from diagnostic submissions may be influenced by study design (e.g., convenience sampling and clinical bias), diagnostic performance and cut-offs, and incomplete demographic denominators, limiting representativeness and comparability.

methodsWe estimated a provincial incidence proxy for CanL during 2022-2023 by combining newly diagnosed cases from routine diagnostic submissions with canine population approximations derived from ISTAT demographic data, applying a baseline dog-to-human ratio of 1:5. Rates were expressed as cases per 10,000 dogs and provinces were classified into five predefined operational risk categories. Robustness was assessed through alternative denominator scenarios (1:4 and 1:6), a restricted registry-based regional analysis in SINAC-covered regions, and descriptive comparison with independent epidemiological, entomological, and ecological evidence.

resultsIncidence estimates revealed substantial heterogeneity across Italy, ranging from 0 to nearly 500 cases per 10,000 dogs. Overall, 49 provinces (45.4%) were classified as minimal risk, 30 (27.8%) as low risk, 21 (19.4%) as moderate risk, 4 (3.7%) as high risk, and 4 (3.7%) as very high risk. Most minimal and low-category provinces were located in northern and central Italy, whereas higher categories were predominantly observed in Southern Italy and Sicily; however, very high provinces were also identified in North-Western Italy (Liguria), notably Imperia and Savona. While absolute provincial values were sensitive to denominator assumptions, registry-based analyses in SINAC-covered regions preserved the regional ranking of incidence, supporting the framework mainly for broad spatial prioritisation rather than precise estimation of absolute burden.

conclusionsIntegrating an incidence proxy alongside prevalence provides a pragmatic surveillance tool for spatial prioritisation and risk communication under real-world constraints. The framework is most informative for identifying higher-burden areas and supporting proportionate prevention and control strategies, especially when interpreted together with registry-based restricted analyses and independent external evidence. Within a One-Health perspective, incidence-based indicators in canine surveillance can improve comparability with routinely used human notification metrics and support coordinated planning across sectors, while remaining distinct in epidemiological meaning between hosts.

Indexed as

Dog DiseasesLeishmaniasisAnimalsDogsHumansIncidenceItalyPrevalencecanine leishmaniosisdogsepidemiologyincidenceItalyzoonoses

Identifiers

PMID42482591
PMCPMC13535707

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.